Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10760097 CMV glycoproteins and recombinant vectors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
November 30, 2017
Date of Patent
September 1, 2020
Patent Application Number
15827649
Patent Citations
‌
US Patent 10101329 CMV glycoproteins and recombinant vectors
‌
US Patent 10167321 Cytomegalovirus antigens and uses thereof
Patent Citations Received
‌
US Patent 11305015 Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
‌
US Patent 10995121 Human cytomegalovirus comprising exogenous antigens
‌
US Patent 11266732 Recombinant HCMV and RHCMV vectors and uses thereof
0
‌
US Patent 11692012 Human cytomegalovirus comprising exogenous antigens
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10760097
Patent Primary Examiner
‌
Rachel B Gill

Find more entities like US Patent 10760097 CMV glycoproteins and recombinant vectors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo